Halozyme Therapeutics
HALO
#2000
Rank
S$10.19 B
Marketcap
$82.52
Share price
-1.75%
Change (1 day)
52.17%
Change (1 year)

P/S ratio for Halozyme Therapeutics (HALO)

P/S ratio as of April 2025 (TTM): 7.53

According to Halozyme Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 21.0. At the end of 2024 the company had a P/S ratio of 6.03.

P/S ratio history for Halozyme Therapeutics from 2005 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.032.44%
20235.89-49.48%
202211.7-8.73%
202112.8-40.81%
202021.674.46%
201912.4-11.3%
201813.953.06%
20179.114.45%
20168.72-46.96%
201516.42.11%
201416.1-48.6%
201331.375.34%
201217.91.63%
201117.6-69.93%
201058.548.53%
200939.4-24.36%
200852.0-64.3%
2007146-74.13%
2006564-33.42%
2005847

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.19-31.06%๐Ÿ‡บ๐Ÿ‡ธ USA
15.7 108.82%๐Ÿ‡บ๐Ÿ‡ธ USA
1.25-83.40%๐Ÿ‡บ๐Ÿ‡ธ USA
2.17-71.26%๐Ÿ‡บ๐Ÿ‡ธ USA
2.85-62.15%๐Ÿ‡ซ๐Ÿ‡ท France
4.34-42.44%๐Ÿ‡บ๐Ÿ‡ธ USA